SCHEMBL4386385

SCHEMBL4386385

[CH2]CNc1nc(NCc2ccc(F)c(Cl)c2)ncc1N

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
BCDIN3D Q7Z5W3 3/20 0.47
GRM4 Q14833 1/20 0.44
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
STK17A Q9UEE5 2/20 0.43
STK17B O94768 1/20 0.43
MAPK1 P28482 2/20 0.41
DYRK1A Q13627 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
NTRK1 P04629 6/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4387694 0.90 DYRK1A (0.41) HDAC3HDAC1HDAC2HDAC6BCDIN3D
SCHEMBL4392092 0.89 RPS6KB1 (0.43) HDAC3HDAC1HDAC2HDAC6BCDIN3D
SCHEMBL4392079 0.84 VNN1 (0.46) HDAC3HDAC1HDAC2HDAC6NTRK1
SCHEMBL4394654 0.82 APP (0.49) HDAC3HDAC1HDAC2HDAC6GRM4
SCHEMBL3189750 0.82 HDAC3 (0.51) HDAC3HDAC1HDAC2HDAC6BCDIN3D
SCHEMBL4385085 0.81 PRKCQ (0.54) HDAC3HDAC1HDAC2HDAC6STK17A
SCHEMBL4385162 0.80 NTRK1 (0.49) NTRK1
SCHEMBL3192454 0.73 HDAC3 (0.41) HDAC3HDAC1HDAC2HDAC6STK17A
SCHEMBL3182040 0.72 SCD (0.47) HDAC3HDAC1HDAC2HDAC6STK17A
SCHEMBL4389712 0.71 PRKCQ (0.54) STK17ADYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2131844-A1 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS CV Therapeutics Inc. (US) 2009-12-16 EP disclosed
WO-2008123891-A1 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS CV THERAPEUTICS, INC. (US) 2008-10-16 WO disclosed